Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - farmaci usati nel diabete - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pregabalinum - capsule - pregabalinum 50 mg, mannitolum, amylum pregelificatum, talcum, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum pro capsula. - antiepilepticum, dolore neuropatico, disturbo d'ansia generalizzata - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - pregabalinum - capsule rigide - pregabalinum 50 mg, lactosum monohydricum 130 mg, maydis amylum, talcum, kapselhülle: gelatina, e 171, e 172 (rubrum) pro capsula. - neuropathische schmerzen, epilepsie, generalisierte angststörungen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - pregabalinum - capsule rigide - pregabalinum 150 mg, lactosum monohydricum 16.50 mg, maydis amylum, talcum, kapselhülle: gelatina, e 171 pro capsula. - neuropathische schmerzen, epilepsie, generalisierte angststörungen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - lacosamidum - compresse rivestite con film - lacosamidum 50 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 132, e 171, e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - aed - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ucb-pharma sa - lacosamidum - compresse rivestite con film - lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum) pro compresso obducto. - aed - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

takeda pharma ag - lisdexamfetamini dimesilas - capsule - lisdexamfetamini dimesilas 50 mg corresp. dexamfetaminum 14.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, kapselhülle: gelatina, e 133, e 171, drucktinte: lacca, propylenglycolum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.2699 mg. - disturbo da deficit di attenzione e iperattività (adhd) - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - pregabalinum - capsule - pregabalinum 150 mg, mannitolum, amylum pregelificatum, talcum, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, e 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum pro capsula. - antiepilepticum, dolore neuropatico, disturbo d'ansia generalizzata - synthetika